Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study

Lignende værker

• Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
  af: Knievel, Kerry, et al.
  Udgivet: (2019)
• Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
  af: Brandes, Jan Lewis, et al.
  Udgivet: (2019)
• The potential of lasmiditan in migraine
  af: Mecklenburg, Jasper, et al.
  Udgivet: (2020)
• Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN
  af: Krege, John H, et al.
  Udgivet: (2019)
• Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
  af: Loo, Li Shen, et al.
  Udgivet: (2019)